... treating patients who experience delayed N&V with cisplatin regimens.[ 25 - 29 ][ Level of evidence: I ] Given their ... mg given each day of a 5-day cisplatin regimen provides additional antiemetic benefit, and it may add ...

... 11 - 16 ][ Level of evidence: 1iiA ] Irinotecan and cisplatin regimens led to less grade 3 to 4 anemia, ... to 4 vomiting and diarrhea than etoposide and cisplatin regimens. Treatment-related deaths were comparable between the two ...

... remains the standard of care.[ 10 ] Mitotane and cisplatin-based regimens: In adults, mitotane is commonly used as a ... advanced adrenocortical tumors treated with mitotane and a cisplatin-based chemotherapeutic regimen, measurable responses were seen in seven patients. The ...

... CI], 83%–89%) for patients who received the cisplatin regimen (n = 620) and 86% (95% CI, 79%–90%) ... for stage I tumors and JEb and other cisplatin-containing chemotherapy regimens for stage II, stage III, and stage IV ...

... doxorubicin, and cisplatin [MVAC]) and three trials utilized cisplatin-based regimens not commonly used in clinical practice (cisplatin and ... vs. 82 months). Three other trials that evaluated cisplatin-based regimens not commonly used in current practice also found ...

... adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam). Annals of Oncology. 1999; 10 (11):1389– ... adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam). Annals of Oncology. 1999; 10 (11):1389– ...

... stage III BRCA1 -associated ovarian cancers treated with cisplatin regimens compared with nonhereditary cancers treated in a similar ...

... Cefalo G, et al.: High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol ... D, et al.: A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma. J Neurooncol ...

... indicated; pancreatoblastoma commonly responds to chemotherapy, and a cisplatin-based regimen is usually recommended. The PLADO regimen, which includes ...

... subsequently had disease recurrence could be salvaged with cisplatin-containing regimens (with or without resection of metastases), yielding a ... This appears to be the most commonly used regimen. EP/EMA: Etoposide and cisplatin with etoposide, methotrexate, and dactinomycin. MAE: Methotrexate with ...